{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:49:22Z","timestamp":1788922162371,"version":"build-2803163510"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Opioid addiction is a significant public health issue, with existing treatments such as buprenorphine and methadone exhibiting limitations, including side effects and insufficient prevention of relapse. Novel therapeutic strategies are needed to address these challenges. This study investigates the potential of dezocine in reducing addiction-related behaviors and preventing relapse.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A morphine-induced conditioned place preference (CPP) model was established in rats to evaluate the effect of dezocine on addiction-related behaviors. Behavioral assessments were conducted to measure withdrawal symptoms and CPP reinstatement. To explore the underlying mechanism, Western blot (WB) and immunofluorescence (IF) were used to quantify the expression of phosphorylated DARPP32 (p-DARPP32) and DOPA decarboxylase (DDC) in reward-related brain regions, including the nucleus accumbens (NAc), ventral tegmental area (VTA), hippocampus (HP), and prefrontal cortex (PFC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Dezocine significantly reduced withdrawal symptoms and prevented CPP reinstatement, indicating its potential to alleviate addiction behaviors. Western blotting and immunofluorescence analysis revealed that dezocine increased p-DARPP32 expression in the NAc, VTA, HP, and PFC, without altering DDC levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>These findings suggest that dezocine may exert its therapeutic effects by inhibiting kappa opioid receptor activation and enhancing dopamine signaling in reward-related brain circuitry. The increase in p-DARPP32 expression in key brain regions supports this mechanism, providing insights into the potential clinical application of dezocine for managing opioid addiction. Dezocine represents a promising candidate for opioid addiction treatment, with the ability to control withdrawal symptoms and prevent relapse.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2025.1507747","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T06:52:43Z","timestamp":1739861563000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Dezocine modulates the reinstatement of conditioned place preference in morphine-dependent rats via the dopamine reward circuitry"],"prefix":"10.3389","volume":"19","author":[{"given":"Yan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Sheng","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Feng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Xiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.bja.2021.12.001","article-title":"Buprenorphine: a treatment and cause of opioid-induced respiratory depression","volume":"128","author":"Albert","year":"2022","journal-title":"Br. J. Anaesth"},{"key":"B2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/npp.2017.133","article-title":"\u03ba-opioid receptor activation in dopamine neurons disrupts behavioral inhibition","volume":"43","author":"Antony","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"109368","DOI":"10.1016\/j.neuropharm.2022.109368","article-title":"Cav1. 3 l-type ca2+ channel-activated CAMKII\/erk2 pathway in the ventral tegmental area is required for cocaine conditioned place preference","volume":"224","author":"Arlene","year":"2023","journal-title":"Neuropharmacology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"19168","DOI":"10.1073\/pnas.0910705106","article-title":"Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking","volume":"106","author":"Benjamin","year":"2009","journal-title":"Proc. Nat. Acad. Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1615\/CritRevNeurobiol.v14.i1.30","article-title":"Herpes simplex virus-mediated gene transfer as a tool for neuropsychiatric research","volume":"14","author":"Carlezon","year":"2000","journal-title":"Crit. Rev. Neurobiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0026-895X(25)13175-1","article-title":"Molecular cloning and functional expression of a mu-opioid receptor from rat brain","volume":"44","author":"Chen","year":"1993","journal-title":"Mol. Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jnr.10801","article-title":"Nonopioid receptor-mediated effects of u-50,488 h on [ca2+] i and extracellular dopamine in pc12 cells","volume":"74","author":"Chudapongse","year":"2003","journal-title":"J. Neurosci. Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"16978","DOI":"10.1038\/s41598-024-67860-7","volume":"14","author":"Cristian","year":"2024"},{"key":"B9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0014-2999(99)00372-6","article-title":"Drug addiction as dopamine-dependent associative learning disorder","volume":"375","author":"Di Chiara","year":"1999","journal-title":"Eur. J. Pharmacol"},{"key":"B10","first-page":"179","volume-title":"Substance and Non-Substance Related Addictions: A Global Approach","author":"Evaristo","year":"2022"},{"key":"B11","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1126\/science.281.5378.838","article-title":"Darpp-32: regulator of the efficacy of dopaminergic neurotransmission","volume":"281","author":"Fienberg","year":"1998","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.psych.59.103006.093548","article-title":"Addiction and the brain antireward system","volume":"59","author":"George","year":"2008","journal-title":"Annu. Rev. Psychol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e70034","DOI":"10.1111\/cns.70034","article-title":"Revisiting dezocine for opioid use disorder: a narrative review of its potential abuse liability","volume":"30","author":"Gordon","year":"2024","journal-title":"CNS Neurosci. Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-023-06030-7","article-title":"Ligand and g-protein selectivity in the \u03ba-opioid receptor","volume":"617","author":"Han","year":"2023","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainres.2011.07.063","article-title":"Suppression of acute morphine withdrawal syndrome by adenovirus-mediated \u03b2-endorphin in rats","volume":"1422","author":"He","year":"2011","journal-title":"Brain Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1021\/acschemneuro.5b00277","article-title":"Enhanced dopamine release by dopamine transport inhibitors described by a restricted diffusion model and fast-scan cyclic voltammetry","volume":"7","author":"Hoffman","year":"2016","journal-title":"ACS Chem. Neurosci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.7326\/AITC202201180","article-title":"Opioid use disorder","author":"Jessica","year":"2022","journal-title":"Ann. Intern. Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-019-0144-6","article-title":"Opioid use disorder","volume":"6","author":"John","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B19","doi-asserted-by":"publisher","first-page":"12917","DOI":"10.1523\/JNEUROSCI.2444-15.2015","article-title":"Kappa opioid receptor-induced aversion requires p38 mapk activation in VTA dopamine neurons","volume":"35","author":"Jonathan","year":"2015","journal-title":"J. Neurosci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7140","DOI":"10.1523\/JNEUROSCI.0876-17.2017","article-title":"Kappa opioid receptors mediate heterosynaptic suppression of hippocampal inputs in the rat ventral striatum","volume":"37","author":"Julie","year":"2017","journal-title":"J. Neurosci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6429","DOI":"10.1038\/s41598-022-09601-2","article-title":"Naloxone's dose-dependent displacement of [11C] carfentanil and duration of receptor occupancy in the rat brain","volume":"12","author":"Kang","year":"2022","journal-title":"Sci. Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"109938","DOI":"10.1016\/j.drugalcdep.2023.109938","article-title":"Buprenorphine reduces somatic withdrawal in a mouse model of early-life morphine exposure","volume":"248","author":"Lepore","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12881-020-01092-0","article-title":"Association studies of dopamine synthesis and metabolism genes with multiple phenotypes of heroin dependence","volume":"21","author":"Li","year":"2020","journal-title":"BMC Med. Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/0028-3908(92)90051-P","article-title":"Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta-and kappa-selective opioid antagonists","volume":"31","author":"Maldonado","year":"1992","journal-title":"Neuropharmacology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"107996","DOI":"10.1016\/j.neuropharm.2020.107996","article-title":"Learned avoidance requires vta kor-mediated reductions in dopamine","volume":"167","author":"Mykel","year":"2020","journal-title":"Neuropharmacology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40263-018-0513-9","article-title":"Pharmacogenetics of opioid use disorder treatment","volume":"32","author":"Richard","year":"2018","journal-title":"CNS Drugs"},{"key":"B27","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.1523\/JNEUROSCI.17-17-06565.1997","article-title":"\u03ba-opioid receptor activation modulates ca2+ currents and secretion in isolated neuroendocrine nerve terminals","volume":"17","author":"Rusin","year":"1997","journal-title":"J. Neurosci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuroscience.2009.06.053","article-title":"Dopamine d1 receptor-dependent modifications in the dopamine and camp-regulated phosphoprotein of MR 32 kda phosphorylation pattern in striatal areas of morphine-sensitized rats","volume":"163","author":"Scheggi","year":"2009","journal-title":"Neuroscience"},{"key":"B29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/jnc.14558","article-title":"Darpp-32 in the orchestration of responses to positive natural stimuli","volume":"147","author":"Scheggi","year":"2018","journal-title":"J. Neurochem"},{"key":"B30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3109\/07853899809029938","article-title":"Neural substrates of drug craving and relapse in drug addiction","volume":"30","author":"Self","year":"1998","journal-title":"Ann. Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainres.2005.02.075","article-title":"Electroacupuncture attenuates morphine withdrawal signs and c-fos expression in the central nucleus of the amygdala in freely moving rats","volume":"1044","author":"Sheng","year":"2005","journal-title":"Brain Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1523\/JNEUROSCI.0274-19.2019","article-title":"Kappa opioid receptors drive a tonic aversive component of chronic pain","volume":"39","author":"Shiwei","year":"2019","journal-title":"J. Neurosci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF02244761","article-title":"Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release","volume":"115","author":"Spanagel","year":"1994","journal-title":"Psychopharmacology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1523\/JNEUROSCI.1978-13.2015","article-title":"\u03ba opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake","volume":"35","author":"Timothy","year":"2015","journal-title":"J. Neurosci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00213-003-1626-4","article-title":"Reassessment of buprenorphine in conditioned place preference: temporal and pharmacological considerations","volume":"172","author":"Tzschentke","year":"2004","journal-title":"Psychopharmacology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1369-1600.2007.00070.x","article-title":"Measuring reward with the conditioned place preference (cpp) paradigm: update of the last decade","volume":"12","author":"Tzschentke","year":"2007","journal-title":"Addict. Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1073\/pnas.0408305102","article-title":"Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum","volume":"102","author":"Valjent","year":"2005","journal-title":"Proc. Nat. Acad. Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00213-008-1122-y","article-title":"Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system","volume":"200","author":"Van","year":"2008","journal-title":"Psychopharmacology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/jamapsychiatry.2018.3126","article-title":"Prevention and treatment of opioid misuse and addiction: a review","volume":"76","author":"Volkow","year":"","journal-title":"JAMA Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"","journal-title":"Physiol. Rev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41401-022-00987-3","article-title":"Upregulation of dynorphin\/kappa opioid receptor system in the dorsal hippocampus contributes to morphine withdrawal-induced place aversion","volume":"44","author":"Yan","year":"2023","journal-title":"Acta Pharmacol. Sin"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.2147\/DDDT.S429752","article-title":"The effect of dezocine on the median effective dose of sufentanil-induced respiratory depression in patients undergoing spinal anesthesia combined with low-dose dexmedetomidine","volume":"17","author":"Yong-Kang","year":"2023","journal-title":"Drug Des. Devel. Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/sj.npp.1300832","article-title":"Phosphorylation of darpp-32 at threonine-34 is required for cocaine action","volume":"31","author":"Zachariou","year":"2006","journal-title":"Neuropsychopharmacology"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1507747\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T06:52:48Z","timestamp":1739861568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1507747\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":43,"alternative-id":["10.3389\/fnins.2025.1507747"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2025.1507747","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"article-number":"1507747"}}